<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01501123</url>
  </required_header>
  <id_info>
    <org_study_id>MCMC 2010-24</org_study_id>
    <nct_id>NCT01501123</nct_id>
  </id_info>
  <brief_title>Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient</brief_title>
  <acronym>PHAST</acronym>
  <official_title>Re-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic Health East</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic Health East</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PREHOSPITAL AGITATION AND SEDATION TRIAL (PHAST)&#xD;
&#xD;
        -  The goal of the PHAST is to demine whether haloperidol is superior to midazolam for the&#xD;
           sedation of agitated patients in the prehospital environment&#xD;
&#xD;
        -  The primary outcome is the time to a Richmond Agitation and Sedation Scale (RASS) ≤1&#xD;
&#xD;
           o The RASS is a well validated standardized score to measure a patient's agitation&#xD;
&#xD;
        -  The secondary outcomes are&#xD;
&#xD;
             -  Time until RASS returns to 0 or 1 if RASS &lt;0&#xD;
&#xD;
             -  Need for additional sedation&#xD;
&#xD;
             -  Adverse effects (need for intubation, arrhythmia)&#xD;
&#xD;
        -  Mercy EMS will be the only EMS agency in the Commonwealth of Pennsylvania carrying&#xD;
           haloperidol&#xD;
&#xD;
        -  Identification of potential study patients will be per state protocols&#xD;
&#xD;
        -  Exclusion Criteria for the study&#xD;
&#xD;
        -  Age &lt;18&#xD;
&#xD;
        -  Pregnant&#xD;
&#xD;
        -  Allergic to study medication&#xD;
&#xD;
        -  Transport to hospital other than Mercy Fitzgerald Hospital&#xD;
&#xD;
        -  Unable to reach medical command prior to giving medication&#xD;
&#xD;
        -  When a paramedic identifies a possible study candidate, the paramedic will consult&#xD;
           medical command to see if the patient is appropriate for the study&#xD;
&#xD;
        -  If the medical command agrees the patient is appropriate for the study, patients will be&#xD;
           randomized to&#xD;
&#xD;
        -  Odd days: Haloperidol 5mg IM (age &lt;65) or haloperidol 2.5 mg IM (age ≥65)&#xD;
&#xD;
        -  Even days: Midazolam 0.05 mg IM to maximum of 5mg IM (age &lt;65) or maximum of 2.5mg (age&#xD;
           ≥65)&#xD;
&#xD;
        -  The RASS will be documented by the prehospital providers every 5 minutes until arrival&#xD;
           at the hospital&#xD;
&#xD;
        -  Once the patient arrives at the ED, the RASS will be documented in PICIS® by the&#xD;
           emergency department nurse at the time of triage and at a minimum of hourly until the&#xD;
           RASS =0 or 1 for 2 consecutive hours&#xD;
&#xD;
        -  Questions may be directed to Dr. Isenberg at disenberg@mercyhealth.org or at (267)&#xD;
           205-6453&#xD;
&#xD;
      Richmond Agitation Sedation Scale&#xD;
&#xD;
      RASS RASS Description&#xD;
&#xD;
        -  4 Combative, violent, danger to staff&#xD;
&#xD;
        -  3 Pulls or removes tube(s) or catheters; aggressive&#xD;
&#xD;
        -  2 Frequent non-purposeful movement&#xD;
&#xD;
        -  1 Anxious, apprehensive, but not aggressive 0 Alert and calm&#xD;
&#xD;
             -  1 Awakens to voice (eye opening/contact) &gt;10 sec&#xD;
&#xD;
             -  2 Light sedation, briefly awakens to voice (eye opening/contact) &lt;10 sec&#xD;
&#xD;
             -  3 Moderate sedation, movement or eye opening. No eye contact&#xD;
&#xD;
             -  4 Deep sedation, no response to voice, but movement or eye opening to physical&#xD;
                stimulation&#xD;
&#xD;
             -  5 Unarousable, no response to voice or physical stimulation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to sedation</measure>
    <time_frame>10 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Agitation</condition>
  <arm_group>
    <arm_group_label>Haloperidol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IM Haloperidol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IM Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Haloperidol</intervention_name>
    <description>5mg IM</description>
    <arm_group_label>Haloperidol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>IM midazolam</description>
    <arm_group_label>IM Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Allergic to study medication&#xD;
&#xD;
          -  Transport to hospital other than Mercy Fitzgerald Hospital&#xD;
&#xD;
          -  Unable to reach medical command prior to giving medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derek Isenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mercy Catholic Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mercy Catholic Medical Center</name>
      <address>
        <city>Darby</city>
        <state>Pennsylvania</state>
        <zip>19023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>December 27, 2011</study_first_submitted>
  <study_first_submitted_qc>December 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2011</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic Health East</investigator_affiliation>
    <investigator_full_name>Derek Isenberg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Time to sedation of agitated patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Haloperidol</mesh_term>
    <mesh_term>Haloperidol decanoate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

